By Michael Ashbaugh, MarketWatch
U.S. stocks are firmly higher early Wednesday, rising amid optimism over positive clinical trial results for a developmental COVID-19 treatment.
Against this backdrop, the S&P 500 has extended its April rally attempt, rising to tag additional resistance (2,934), a level defining the 62% Fibonacci retracement of the 2020 crash.
